Literature DB >> 16084086

Quantification of mobility impairment and self-assessment of stiffness in patients with myotonia congenita by the physiotherapist.

Elisabet Hammarén1, Gunilla Kjellby-Wendt, Christopher Lindberg.   

Abstract

We investigated test-retest reliability and responsiveness in two functional measuring instruments, Timed Up&Go (TUG) and Timed-Stands Test (TST), and in three self-assessment scales, Visual Analogue Scale (VAS), Borg's Category-Ratio Scale (BorgCR10) and Myotonia Behaviour Scale (MBS) when quantifying myotonic stiffness and mobility impairment. These methods were used in the assessment of treatment efficacy of mexiletine. Six male patients with myotonia congenita followed a standardised protocol with time scoring and rest on two occasions, with and without mexiletine. Time scoring of TUG and TST and self-assessments of stiffness were performed. A 14-day stiffness diary was used at home. Timed Up&Go and TST showed very good test-retest agreement (ICC=0.87-0.95) and significant to change (P=0.005 and 0.001, respectively). All self-assessment scales revealed excellent responsiveness and good test-retest reliability. The measurement instruments possess great capacity to detect functional impairment in the myotonia congenita patient group, and sensibility to identify true changes due to treatment. When considering the results, three instruments are favoured; Timed Up&Go and BorgCR10 for short, and MBS for long-term evaluations.

Entities:  

Mesh:

Year:  2005        PMID: 16084086     DOI: 10.1016/j.nmd.2005.07.002

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  8 in total

1.  Effect of Mexiletine on Muscle Stiffness in Patients With Nondystrophic Myotonia Evaluated Using Aggregated N-of-1 Trials.

Authors:  Bas C Stunnenberg; Joost Raaphorst; Hans M Groenewoud; Jeffrey M Statland; Robert C Griggs; Willem Woertman; Dick F Stegeman; Janneke Timmermans; Jaya Trivedi; Emma Matthews; Christiaan G J Saris; Bas J Schouwenberg; Gea Drost; Baziel G M van Engelen; Gert Jan van der Wilt
Journal:  JAMA       Date:  2018-12-11       Impact factor: 56.272

Review 2.  Treatment Updates for Neuromuscular Channelopathies.

Authors:  Nantaporn Jitpimolmard; Emma Matthews; Doreen Fialho
Journal:  Curr Treat Options Neurol       Date:  2020-08-22       Impact factor: 3.598

3.  Oral motor movements and swallowing in patients with myotonic dystrophy type 1.

Authors:  Beatriz Ercolin; Fernanda Chiarion Sassi; Laura Davison Mangilli; Lucia Iracema Zanotto Mendonça; Suelly Cecilia Olivan Limongi; Claudia Regina Furquim de Andrade
Journal:  Dysphagia       Date:  2013-03-05       Impact factor: 3.438

Review 4.  The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment.

Authors:  E Matthews; D Fialho; S V Tan; S L Venance; S C Cannon; D Sternberg; B Fontaine; A A Amato; R J Barohn; R C Griggs; M G Hanna
Journal:  Brain       Date:  2009-11-16       Impact factor: 13.501

5.  Impaired Wheel Running Exercise in CLC-1 Chloride Channel-Deficient Myotonic Mice.

Authors:  Erik van Lunteren; Michelle Moyer; Jessica Cooperrider; Jennifer Pollarine
Journal:  Front Physiol       Date:  2011-08-09       Impact factor: 4.566

6.  Combined N-of-1 trials to investigate mexiletine in non-dystrophic myotonia using a Bayesian approach; study rationale and protocol.

Authors:  Bas C Stunnenberg; Willem Woertman; Joost Raaphorst; Jeffrey M Statland; Robert C Griggs; Janneke Timmermans; Christiaan G Saris; Bas J Schouwenberg; Hans M Groenewoud; Dick F Stegeman; Baziel G M van Engelen; Gea Drost; Gert Jan van der Wilt
Journal:  BMC Neurol       Date:  2015-03-25       Impact factor: 2.474

7.  Muscle Ultrasound Shear Wave Elastography as a Non-Invasive Biomarker in Myotonia.

Authors:  Cornelius Kronlage; Alexander Grimm; Alyssa Romano; Jan-Hendrik Stahl; Pascal Martin; Natalie Winter; Justus Marquetand
Journal:  Diagnostics (Basel)       Date:  2021-01-23

8.  Identification of canine osteoarthritis using an owner-reported questionnaire and treatment monitoring using functional mobility tests.

Authors:  A Wright; D M Amodie; N Cernicchiaro; B D X Lascelles; A M Pavlock; C Roberts; D J Bartram
Journal:  J Small Anim Pract       Date:  2022-04-06       Impact factor: 1.669

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.